BCG vaccination as protection from COVID-19: epidemiological and molecular biological aspects-Reference-Cited by-同舟云学术

BCG vaccination as protection from COVID-19: epidemiological and molecular biological aspects

Published:2020-06-03 Issue:5 Volume:98 Page:6-14
ISSN:2542-1506
Container-title:Tuberculosis and Lung Diseases
language:
Short-container-title:Tuberk. bolezni lëgk.

Author:

Shvartz Ya. Sh.¹,Stavitskaya N. V.¹,Kudlay D. A.²^ORCID

Affiliation:

1. Novosibirsk Tuberculosis Research Institute

2. NRC Institute of Immunology FMBA of Russia

Abstract

The article presents a review of the recent hypothesis that the national policy of BCG-vaccination affects the spread of COVID-19 in different countries. It contains the information from 70 publications with epidemiological indicators, providing pros and cons of this hypothesis, with the description of possible mechanisms of non-specific antiviral action of BCG vaccine. It is concluded that there are not enough data to verify or refute the hypothesis, and at the moment the use of BCG vaccine to prevent the spread of the infection even in high-risk groups would be unreasonable.

Publisher

New Terra

Subject

General Medicine

Reference72 articles.

1. Shvarts Ya.Sh., Belogorodtsev S.N., Filimonov P.N., Seledtsova G.V. Effects of mevalonate pathway modulators upon reactivity of macrophages in experimental nephrosclerosis. Med. Immunologiya, 2009, no. 11, pp. 499-508. (In Russ.)

2. Shvarts Ya.Sh., Khoschenko O.M., Dushkin M.I., Feofanova N.А. The effect of cholesterol and agonists of hormonal nuclear receptors on the production of the transforming growth factor-β in macrophages. Byul. Eksperim. Biologii I Meditsiny, 2009, no. 148, pp. 294-297. (In Russ.)

3. Aaby P., Kollmann T., Benn C. Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges. Nat. Immunol., 2014, no. 15, pp. 895-899. https://doi.org/10.1038/ni.2961.

4. Abubakar I., Pimpin L., Ariti C., Beynon R., Mangtani P. et al. Systematic review and meta-analysis of the current evidence on the duration of protection by Bacillus Calmette-Guérin vaccination against tuberculosis. Health Technol. Assess., 2013, no. 37, pp. 1-372. doi: 10.3310/hta17370.

5. Allen I.C., Scull M.A., Moore C.B., Holl E.K., McElvania-TeKippe E. et al. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity, 2009, vol. 30, no. 4, pp. 556-565.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tuberculosis and COVID-19: Medical and Social Aspects;Tuberculosis and Lung Diseases;2022-04-06

2. Local complications and lymphadenitis after BCG–M vaccination in children – сhoosing the right tactics;Journal Infectology;2021-07-14

3. The psychosocial impact on society of the COVID-19 epidemic;Bulletin of the Russian Military Medical Academy;2021-05-12